ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,034Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 1692

$1.6M Total Retail Price of All Prescriptions

Rank: 8 out of 1692

706 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 706 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 706 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 17,210 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
PRAVASTATIN SODIUM 1,334 952 1 12
LEVOTHYROXINE SODIUM 1,304 985 2 4
OMEPRAZOLE 1,005 627 3 5
HYDROCODONE-ACETAMINOPHEN 904 381 S3 4 6
METFORMIN HCL 631 422 5 8
BENAZEPRIL HCL 572 356 6 69
FUROSEMIDE 561 406 7 7
ATENOLOL 557 427 8 15
AMLODIPINE BESYLATE 555 451 9 3
GABAPENTIN 485 272 10 13
HYDROCHLOROTHIAZIDE 445 322 11 9
TRAMADOL HCL 430 245 12 16
METOPROLOL TARTRATE 374 276 13 10
LISINOPRIL 369 252 14 2
CITALOPRAM HBR 326 251 15 21
POTASSIUM CHLORIDE 295 235 16 20
MELOXICAM 293 194 17 41
ZOLPIDEM TARTRATE 255 128 18 23
NEXIUM 248 156 19 25
SERTRALINE HCL 246 197 20 22
GLIMEPIRIDE 243 181 21 32
AZITHROMYCIN 233 158 22 34
CRESTOR 229 167 23 26
WARFARIN SODIUM 227 164 24 14
CYMBALTA 219 74 25 51
MIRTAZAPINE 219 162 25 53
ATORVASTATIN CALCIUM 216 151 27 11
TAMSULOSIN HCL 212 189 28 31
SIMVASTATIN 204 179 29 1
LOVASTATIN 197 126 30 37
TRIAMTERENE-HCTZ 190 162 31 61
AMITRIPTYLINE HCL 183 128 R 32 58
TRAZODONE HCL 177 115 33 33
LOSARTAN POTASSIUM 176 148 34 17
PANTOPRAZOLE SODIUM 167 81 35 39
METHYLPREDNISOLONE 159 109 36 160
ISOSORBIDE MONONITRATE ER 153 114 37 55
ZETIA 150 83 38 68
DONEPEZIL HCL 149 137 39 29
CIPROFLOXACIN HCL 148 108 40 65
METOPROLOL SUCCINATE 146 108 41 18
RANITIDINE HCL 145 87 42 28
SPIRIVA 140 96 43 44
ROPINIROLE HCL 139 108 44 101
FLUTICASONE PROPIONATE 138 88 45 27
BENAZEPRIL-HYDROCHLOROTHIAZIDE 133 94 46 177
DIOVAN 126 99 47 42
LOSARTAN-HYDROCHLOROTHIAZIDE 124 91 48 38
ALENDRONATE SODIUM 122 112 49 36
DIGOXIN 121 85 50 85
CLOPIDOGREL 119 88 51 43
FENOFIBRATE 112 59 52 63
JANUVIA 112 78 52 72
ABILIFY 110 30 54 194
ALLOPURINOL 110 92 54 30
DIOVAN HCT 110 94 54 73
AMOX TR-POTASSIUM CLAVULANATE 109 69 57 161
SULFAMETHOXAZOLE-TRIMETHOPRIM 106 61 58 100
FLUOXETINE HCL 104 63 59 52
CARVEDILOL 102 82 60 24
LYRICA 102 16 60 111
TIZANIDINE HCL 100 31 62 127
TERAZOSIN HCL 97 80 63 128
CLONIDINE HCL 97 76 63 46
SYNTHROID 96 85 65 59
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 78 65 19
BUSPIRONE HCL 95 37 67 122
PREDNISONE 94 53 68 35
VENLAFAXINE HCL 89 60 69 190
DOXAZOSIN MESYLATE 88 88 70 83
MECLIZINE HCL 86 79 71 124
BUPROPION XL 83 29 72 235
PLAVIX 81 60 73 66
RISPERIDONE 81 37 73 77
CYCLOBENZAPRINE HCL 80 37 R 75 54
NABUMETONE 80 55 75 158
LANSOPRAZOLE 79 57 77 133
VENLAFAXINE HCL ER 78 56 78 84
NITROSTAT 75 47 79 225
ENALAPRIL MALEATE 75 49 79 71
AVODART 74 74 81 173
PEN NEEDLE 73 38 82 168
PROAIR HFA 73 34 82 40
FLUCONAZOLE 73 55 82 175
CARBIDOPA-LEVODOPA 70 60 85 110
QUETIAPINE FUMARATE 68 25 86 62
LANTUS 67 53 87 57
AMLODIPINE BESYLATE-BENAZEPRIL 66 54 88 67
PROPRANOLOL HCL 66 28 88 109
COMBIVENT 65 44 90 141
HYDROXYZINE PAMOATE 65 11 R 90 211
BYSTOLIC 65 65 90 129
BACLOFEN 63 12 93 115
CILOSTAZOL 63 48 93 232
TOPIRAMATE 63 16 93 164
PROMETHAZINE HCL 62 23 R 96 81
KLOR-CON M20 62 57 96 48
METHOTREXATE 61 46 98 349
FINASTERIDE 60 60 99 99
NIASPAN 59 36 100 123
CARISOPRODOL 58 0 R 101 137
OXYCODONE HCL 58 13 S2 101 56
ESCITALOPRAM OXALATE 58 45 101 76
SPIRONOLACTONE 58 0 101 74
TRICOR 58 32 101 112
RAMIPRIL 57 46 106 108
AMOXICILLIN 56 37 107 95
SEROQUEL XR 55 26 108 278
OXYCODONE HCL-ACETAMINOPHEN 54 14 S2 109 94
DEXILANT 54 48 109 196
SUCRALFATE 53 36 111 172
SINGULAIR 53 34 111 79
HYDROXYCHLOROQUINE SULFATE 52 21 113 287
INSULIN SYRINGE 51 36 114 93
WELCHOL 51 39 114 217
DILTIAZEM 24HR CD 51 51 114 96
LANTUS SOLOSTAR 50 21 117 102
NAPROXEN 50 16 117 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.